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1.001
he Challenges of Travel Medicine in the 21st Century
. Loutan
Geneva University Hospitals, Geneva, Switzerland
Travel medicine has emerged as a new ﬁeld of medicine,
oving to an evidence based body of knowledge concerning
isk assessment and measures to protect the health of trav-
llers. Most of travel medicine concentrates on tourists from
orth America and Europe leaving for international destina-
ions, many being low or middle income countries involving
higher risk of acquiring infectious diseases. This paradigm
s changing rapidly. With the increasing mobility of popu-
ations, whether migrants, tourists, businessmen, students,
oldiers, humanitarian workers, pilgrims, refugees or med-
cal tourists, it is becoming evident that the diversiﬁcation
f globally mobile travelers is posing new challenges to the
ravel medicine community. Perception of risk, behaviour,
xposure to risks and access to health services vary enor-
ously. Nonetheless all contribute to the global circulation
nd potential spread of known or emerging pathogens. From
n epidemiological and public health perspective a more
lobal encompassing approach to health issues related to
opulation mobility is urgently needed.
With globalisation new emerging economies are growing
n many parts of the world, new patterns of travel and mobil-
ty appear. The sharpest increases in travel are observed in
sian and in Latin American regions where intra-regional and
n-country travel is rising. The majority of these new trav-
llers are urban dwellers often unaware of the existing risks
radients within their own country when they move to rural
estinations. Thus travel medicine has to expand from the
urrent international/across boarders approach to a prac-
ice based on risk assessment analysis and prevention across
ifferent prevalence gaps, wherever and for whomever they
re of relevance.
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oi:10.1016/j.ijid.2010.02.003Climate change, security issues, economic ﬂuctuations,
emographic shifts and the threat of emerging diseases will
lso reshape the future of travel and mobility trends. All
ill inﬂuence travelers’ health and pose new challenges to
ravel medicine in the forthcoming decades.
oi:10.1016/j.ijid.2010.02.1476
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2.001
evelopment of Travel Medicine in Latin America
. Lepetic
GSK, Buenos Aires, Argentina
No abstract received.
oi:10.1016/j.ijid.2010.02.1477
2.002
pproach to pre-travel consultation
. Acun˜a
Santiago, Chile
La consejería pre-viaje debe considerar varios aspec-
os: la persona que consulta por lo general no está
nferma, no entiende muy bien la necesidad de una consulta
édica.
El Médico debe considerar condiciones del viajero (edad,
exo,posible embarazo, patologías previas y condiciones
ctuales, medicamentos que ingiere alergias, etc).
Es relevante el itinerario antes de llegar al destino y
ctividades en zona a visitar, condiciones de alojamiento,
omida, y transporte.
El Centro debe contar con Vacunatorio ad-hoc, productos
ecesarios para proﬁlaxis de Malaria, picadura demosquitos,
otiquín del viajero, puriﬁcadores de agua.
